Loading company
Protagenic Therapeutics, Inc.\new
PTIX · OTC
$0.740.0%Sep 25 close
- 1M
- 0.0%
- 6M
- 0.0%
- 1Y
- -78.4%
- 5Y
- -99.4%
PTIX · OTC
$0.740.0%Sep 25 close
The quarter ending March 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toMar 31, 2026 | 3 months toMar 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $0.00 | $0.00 | — |
| Profit | -$963.6K | -$5.1M | +80.95% |
| Profit per share | -$0.53 | -$1.37 | +61.31% |
| Free Cash Flow | -$1.2M | -$80K | -1,448.00% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Protagenic Therapeutics, Inc.\new has no earnings call transcript available.
The quote and the company description come from Protagenic Therapeutics, Inc.\new’s Item 2.02 8-K filed April 1, 2011; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.